Partially modified retro-inverso pseudopeptides as non-natural ligands for the human class I histocompatibility molecule HLA-A2

Journal of Medicinal Chemistry

Volumn 39, Issue 10, 1996, Pages 2030-2039

  Guichard, Gilles ^a   Connan, Francine ^c   Graff, Roland ^b   Ostankovitch, Marina ^c   Muller, Sylviane ^a   Guillet, Jean Gérard ^c   Chopping, Jeannine ^c   Briand, Jean Paul ^a  

^a INSTITUT DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b UNIVERSITÉ LOUIS PASTEUR   (France)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MATRIX PROTEIN; T LYMPHOCYTE RECEPTOR; VIRUS PROTEIN;

AMINO ACID SUBSTITUTION; ANTIGEN BINDING; ARTICLE; CELLULAR IMMUNITY; ENZYME LINKED IMMUNOSORBENT ASSAY; INFLUENZA VIRUS; LIGAND BINDING; PROTEIN BINDING; PROTEIN STRUCTURE; STRUCTURE ACTIVITY RELATION;

AMINO ACID SEQUENCE; HLA-A2 ANTIGEN; HUMANS; LIGANDS; MOLECULAR SEQUENCE DATA; ORTHOMYXOVIRIDAE; PEPTIDES; PROTEIN BINDING; SPECTROMETRY, MASS, FAST ATOM BOMBARDMENT; TUMOR CELLS, CULTURED; VIRAL MATRIX PROTEINS;

EID: 0030007650     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm9509511     Document Type: Article

References (62)

1. Townsend, A.; Bodmer, H. Antigen Recognition by class I-restricted T lymphocytes. Annu. Rev. Immunol. 1989, 7, 601-624.
2. Falk, K.; Rötzschke, O.; Stevanovic, S.; Jung, G.; Rammensee, H.-G. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 1991, 351, 290-296.
3. Bjorkman, P. J.; Saper, M. A.; Samraoui, B.; Bennett, W. S.; Strominger, J. L.; Wiley, D. C. Structure of the human class I histocompatibility antigen, HLA-A2. Nature 1987, 329, 506-512. Bjorkman, P. J.; Saper, M. A; Samraoui, B.; Bennett, W. S.; Strominger, J. L.; Wiley, D. C. The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature 1987, 329, 512-518.
4. Bjorkman, P. J.; Saper, M. A.; Samraoui, B.; Bennett, W. S.; Strominger, J. L.; Wiley, D. C. Structure of the human class I histocompatibility antigen, HLA-A2. Nature 1987, 329, 506-512. Bjorkman, P. J.; Saper, M. A; Samraoui, B.; Bennett, W. S.; Strominger, J. L.; Wiley, D. C. The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature 1987, 329, 512-518.
5. Madden, D. R.; Gorga, J. L.; Strominger, J. L.; Wiley, D. C. Structure of HLA-B27 reveals nonamer self peptides bound in an extended conformation. Nature 1991, 353, 321-325.
6. Saper, M. A.; Bjorkman, P. J.; Wiley, D. C. Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 Å resolution. J. Mol. Biol. 1991, 219, 277-319.
7. Silver, M. L.; Guo, H.-C.; Strominger, J. L.; Wiley, D. C. Atomic structure of a human MHC molecule presenting an influenza virus peptide. Nature 1992, 360, 367-369.
8. Madden, D. R.; Gorga, J. L.; Strominger, J. L.; Wiley, D. C. The three-dimentional structure of HLA-B27 at 2.1 Å resolution suggests a general mechanism for tight peptide binding to MHC. Cell 1992, 70, 1035-1048.
9. b. Science 1992, 257, 919-927. Matsumura, M.; Fremont, D. H.; Stura, E. A.; Peterson, P. A.; Wilson, I. A. Emerging principles for the recognition of peptide antigens by MHC Class I molecules. Science 1992, 257, 927-934.
10. b. Science 1992, 257, 919-927. Matsumura, M.; Fremont, D. H.; Stura, E. A.; Peterson, P. A.; Wilson, I. A. Emerging principles for the recognition of peptide antigens by MHC Class I molecules. Science 1992, 257, 927-934.
11. Madden, D. R.; Garboczi, D. N.; Wiley, D. C. The antigenic identity of peptide-MHC complexes: A comparison of the conformations of five viral peptides presented by HLA-A2. Cell 1993, 75, 693-708.
12. b at 2.4 Å resolution: implications for antigen-determinant selection. Cell 1994, 76, 39-50.
13. Young, A. C. M.; Nathenson, S. G.; Sacchettini, J. C. Structural studies of class I major histocompatibility complex proteins: insights into antigen presentation. FASEB J. 1995, 9, 26-36.
14. Parker, K. C.; Bednarek, M. A.; Hull, L. K.; Utz, U.; Cunningham, B.; Zweerink, H. J.; Biddison, W. E.; Coligan, J. E. Sequence motifs important for peptide binding to the human MHC class I molecule, HLA-A2. J. Immunol. 1992, 149, 3580-3587.
15. Hunt, D. F.; Henderson, R. A.; Shabanowitz, J.; Sakaguchi, K.; Michel, H.; Sevilir, N.; Cox, A. L.; Appelle, E.; Engelhard, V. H. Characterisation of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectroscopy. Science 1992, 255, 1261-1263.
16. Appella, E.; Loftus, D. J.; Sakaguchi, K.; Sette, A.; Celis, E. Synthetic antigenic peptides as a new strategy for immunotherapy of cancer. Biomed. Pept., Proteins Nucleic Acids 1995, 1, 177-184.
17. Melief, C. J. M.; Kast, M. T-cell immunotherapy of tumors by adoptive transfer of cytotoxic T lymphocytes and by vaccination with minimal essential epitopes. Immunol. Rev. 1995, 146, 167-177.
18. Guillet, J. G.; Lai, M.-Z.; Brinner, T.; Smith, J. A.; Gefter, M. L. Interaction of peptide antigens and class II major histocompatibility complex antigens. Nature 1986, 324, 260-262.
19. Grey, H. M.; Sette, A.; Lamont, A. Biologic significance and therapeutic implications of antigen-MHC interactions. Clin. Immunol. Immunopathol. 1989, 53, S47-S52.
20. Lamont, A. G.; Sette, A.; Fujinami, R.; Colon, S. M.; Miles, C.; Grey, H. M. Inhibition of experimental autoimmune encephalomyelitis induction in SJL/J mice by using a peptide with high affinity for IAs molecules. J. Immunol. 1990, 145, 1687-1693.
21. De Magistris, M. T.; Alexander, J.; Coggeshall, M.; Altman, A.; Gaeta, F. C. A.; Grey, H. M.; Sette, A. Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor. Cell 1992, 68, 625-634.
22. Jameson, S. C.; Carbone, F. R.; Sevan, J. Clone specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells. J. Exp. Med. 1993, 177, 1541-1550.
23. Bertoletti, A.; Sette, A.; Chisari, F. V.; Penna, A.; Levrero, M.; DeCarli, M.; Fiaccadori, F.; Ferrari, C. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature 1994, 369, 407-410.
24. Sloan-Lancaster, J.; Allen, P. M. Significance of T-cell stimulation by altered peptide ligands in T cell biology. Curr. Opin. Immunol. 1995, 7, 103-109.
25. Sette, A.; Alexander, J.; Ruppert, J.; Snoke, K.; Franco, A.; Ishioka, G.; Grey, H. M. Antigen analogs/MHC complexes as specific T cell receptor antagonists. Annu. Rev. Immunol. 1994, 12, 413-431.
26. Karin, N.; Mitchell, D. N.; Brocke, S.; Ling, N.; Steinman, L. Reversal of experimental autoimmune encephalomyelitis by a soluble peptide variant of a myelin basic protein epitope: T cell receptor antagonism and reduction of interferon γ and tumor necrosis factor α production. J. Exp. Med. 1994, 180, 2227-2237.
27. Kuchroo, V. K.; Greer, J. M.; Deepak, K.; Ishioka, G.; Franco, A.; Sette, A.; Sobel, R. A.; Lees, M. B. A single TCR antagonist peptide inhibits experimental allergic encephalomyelitis mediated by a diverse T cell repertoire. J. Immunol. 1994, 153, 3326-3336.
28. Jameson, S. C.; Bevan, M. J. T cell receptor antagonists and partial agonists. Immunity 1995, 2, 1-11.
29. Lamont, A. G.; Powell, M. F., Colon, S. M.; Miles, C.; Grey, H. M.; Sette, A. The use of peptide analogs with improved stability and MHC binding capacity to inhibit antigen presentation in vitro and in vivo. J. Immunol. 1990, 144, 2493-2498.
30. Widmann, C.; Maryanski, J. L.; Romero, P.; Corradin, G. Differential stability of antigenic MHC class I-restricted synthetic peptides. J. Immunol. 1991, 147, 3745-3751.
31. Chorev, M.; Shavitz, R.; Goodman, M.; Minick, S.; Guillemin, R. Partially modified retro-inverso-enkephalinamides: Topochemichal long-lasting analogs in vitro and in vivo. Science 1979, 204, 1210-1212.
32. 2 modification. J. Med. Chem. 1991, 34, 3372-3379.
33. Doulut, S.; Rodriguez, M.; Lugrin, D.; Vecchini, F.; Kitabgi, P.; Aumelas, A.; Martinez, J. Reduced peptide bond pseudopeptide analogues of neurotensin. Pept. Res. 1992, 5, 30-38.
34. Chorev, M.; Goodman, M. A dozen years of retro-inverso pepti-domimetics. Acc. Chem. Res. 1993, 26, 266-273.
35. Martinez, J.; Bali, J. P.; Rodriguez, M.; Castro, B.; Magous, R.; Laur, J.; Lignon, M. F. Synthesis and biological activities of some pseudo-peptide analogues of tetragastrin: The importance of peptide backbone. J. Med. Chem. 1985, 28, 1874-1879.
36. Rodriguez, M.; Lignon, M. F.; Galas, M. C.; Fulcrand, P.; Mendre, C.; Aumelas, A.; Laur, J.; Martinez, J. Synthesis and biological activities of pseudopeptide analogues of the C-terminal heptapeptide of cholecystokinin. On the importance of peptide bonds. J. Med. Chem. 1987, 30, 1366-1373.
37. Rodriguez, M.; Dubreuil, P.; Bali, J. P.; Martinez, J. Synthesis and biological activity of partially modified retro-inverso pseudopeptide derivatives of the C-terminal tetrapeptide of gastrin. J. Med. Chem. 1987, 30, 758-763.
38. Coy, D. H.; Taylor, J. E.; Jiang, N. Y.; Kim, S. H.; Wang, L. H.; Huang, S. C.; Moreau, J. P.; Gardner, J. D.; Jensen, R. T. Short-chain pseudopeptide bombesin receptor antagonists with enhanced binding affinities for pancreatic acinar and swiss 3T3 cells display strong antimitotic activity. J. Biol. Chem. 1989, 264, 14691-14697.
39. Schiller, P. W.; Weltrowska, G.; Nguyen, T. M. D.; Wilkes, B. C.; Chung, N.; Lemieux, C. TIPP[ψ]: a highly potent and stable pseudopeptide δ opioid receptor antagonist with extraordinary δ selectivity. J. Med. Chem. 1993, 36, 3182-3187.
40. 2 C terminus. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 1922-1926.
41. Guichard, G.; Benkirane, N.; Zeder-Lutz, G.; Van Regenmortel, M. H. V.; Briand, J. P.; Muller, S. Antigenic mimicry of natural L-peptides with retro-inverso-peptidomimetics. Proc. Natl. Acad. Sci. U.SA. 1994, 91, 9765-9769.
42. Guichard, G.; Benkirane, N.; Muller, S.; Briand, J. P. Synthesis and antigenic properties of reduced peptide bond pseudopeptide analogues of a histone H3 hexapeptide. Pept. Res. 1994, 7, 308-321.
43. Benkirane, N.; Guichard, G.; Van Regenmortel, M. H. V.; Briand, J. P.; Muller, S. Cross-reactivity of antibodies to retro-inverso peptidomimetics with the parent protein histone H3 and chromatin core particle: Specificity and kinetic rate-constant measurements. J. Biol. Chem. 1995, 270, 11921-11926.
44. Muller, S.; Guichard, G.; Benkirane, N.; Brown, F.; Van Regenmortel, M. H. V.; Briand, J. P. Enhanced immunogenicity and cross-reactivity of retro-inverso peptidomimetics of the major antigenic site of foot-and-mouth disease virus. Pept. Res. 1995, 8, 138-144.
45. Briand, J. P.; Guichard, G.; Dumortier, H.; Muller, S. Retroinverso peptidomimetics as new immunological probes: validation and application to the detection of antibodies in rheumatic diseases. J. Biol. Chem. 1995, 270, 20686-20691.
46. Dürr, H.; Goodman, M.; Günther, J. Retro-inverso amide bonds between trifunctional amino acids. Angew. Chem., Int. Ed. Engl. 1992, 31, 785-787.
47. Hill, C. M.; Liu, A.; Marshall, K. W.; Mayer, J.; Jorgensen, B.; Yuan, B.; Cubbon, R. M.; Nichols, E. A.; Wicker, L. S.; Rothbard, J. B. Exploration of requirements for peptide binding to HLA DRB1*0101 and DRB1*0401. J. Immunol. 1994, 152, 2890-2898.
48. Rognan, D.; Scapozza, L.; Folkers, G.; Daser, A. Rational design of nonnatural peptides as high affinity ligands for HLA-B*2705 human leucocyte antigen. Proc. Natl. Acad. Sci. U.S.A 1995, 92, 753-757.
49. Weiss, G. A.; Collins, E. J.; Garboczi, D. N.; Wiley, D. C.; Schreiber, S. L. A tricyclic ring system replaces the variable regions of peptides presented by three alleles of human MHC class I molecules. Chem. Biol. 1995, 2, 401-407.
50. Guichard, G.; Calbo, S.; Muller, S.; Kourilsky, P.; Briand, J. P.; Abastado, J. P. Efficient binding of reduced peptide bond pseudopeptides to major histocompatibility complex class I molecule. J. Biol. Chem. 1995, 270, 26057-26059.
51. Bednarek, M. A.; Suma, S. Y.; Gammon, M. C.; Porter, G.; Tamhankar, S.; Williamson, A. R.; Zweerinck, H. J. The minimum peptide epitope from the influenza virus matrix protein. Extra and intracellular loading of HLA-A2. J. Immunol. 1991, 147, 4047-4053.
52. Parker, K. C.; Bednarek, M. A.; Hull, L. K.; Utz, U.; Cunningham, B.; Zweerink, H. J.; Biddison, W. E.; Colligan, J. E. Sequence motifs important for peptide binding to the human MHC class I molecule, HLA-A2. J. Immunol. 1992, 140, 3580-3587.
53. 4 amide bond. Int. J. Pept. Protein Res. 1985, 25, 648-662.
54. Loudon, G. M.; Almond, M. R.; Jacob, J. N. Mechanism of hydrolysis of N-(1-Aminoalkyl) amides. J. Am. Chem. Soc. 1981, 103, 4508-4515.
55. Hrubowchak, D. M.; Smith, F. X. The reductive alkylation of Meldrum's acid. Tetrahedron Lett. 1983, 4951-4954.
56. Chorev, M.; Rubini, E.; Gilon, C.; Wormser, U.; Selinger, Z. Synthesis of partially modified retro-inverso substance P analogues and their biological activity. J. Med. Chem. 1983, 26, 129-135.
57. Connan, F.; Hlavac, F.; Hoebeke, J.; Guillet, J.-G.; Choppin, J. A simple assay for detection of peptides promoting the assembly of HLA class I molecules. Eur. J. Immunol. 1994, 24, 777-780.
58. Bax, Ad.; Davies, D. G. Practical aspects of two-dimentional transverse NOE spectroscopy. J. Magn. Reson. 1985, 63, 207-213.
59. Davis, A. L.; Laue, E. D.; Keeler, J.; Moskau, D.; Lohman, J. Absorption-mode two-dimentional NMR spectra recorded using pulsed field gradients. J Magn. Reson. 1991, 94, 637-644.
60. Salter, R. D.; Cresswell, P. Impaired assembly and transport of HLA-A and B-antigens in a mutant TxB cell hybrid. EMBO J. 1986, 5, 943-949.
61. Teillaud, J.-L.; Crevat, D.; Chardon, P.; Kalil, J.; Goujet-Zalc, C.; Mahouy, G.; Vaiman, M.; Fellous, M.; Pious, D. Monoclonal antibodies as a tool for phylogenetic studies of major histocompatibility antigens and β2-microglobulin. Immunogenetics 1982, 15, 377-384.
62. Do Ngoc Lien, D.; Cesari, I. M.; Bouty, I.; Bout Hoebeke, J. Immunocapture assay for quantification of human IgA antibodies to parasite antigenic enzyme. Application with the alkaline phosphatase of "schistosoma mansoni". J. Immunoassay 1992, 13, 521-536.